SCOPUS 정보 검색 플랫폼

Current Opinion in Investigational Drugs

Volumn 2, Issue 11, 2001, Pages 1516-1522

Hepatitis C virus: Prospects for future therapies

Author keywords

Combination therapy; Hepatitis C virus; Interferon; NS3; NS3 helicase; NS4A protease; NS5B RNA dependent RNA polymerase; PEGylated interferon

Indexed keywords

ALPHA INTERFERON; ALPHA KETOAMIDE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; BORONIC ACID DERIVATIVE; HCI 436; HELICASE; HELICASE INHIBITOR; HEXAPEPTIDE INHIBITOR; INTERFERON; LEVOVIRIN; MACROGOL; MERIMEPODIB; NS3 PROTEINASE; NS4A PROTEINASE; NS5B RNA DIRECTED DNA POLYMERASE; PHOSPHONIC ACID DERIVATIVE; PROTEINASE; PROTEINASE INHIBITOR; REBETRON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIPEPTIDE ACID INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS RNA; VP 50406;

ANTIVIRAL ACTIVITY; BINDING SITE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FOLLOW UP; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IN VIVO STUDY; MONOTHERAPY; NONHUMAN; PHARMACODYNAMICS; PROTEIN PROTEIN INTERACTION; REVIEW; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS;

EID: 0035185968 PISSN: 14724472 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (7)

References (58)

1
- 0035811625
- Hepatitis C virus infection
- note
- (2001) New Engl J Med , vol.345 , pp. 41-52
- Lauer, G.M.¹ Walker, B.D.²

2
- 0030955346
- Epidemiology of hepatitis C
- (1997) Hepatology , vol.26 , Issue.3 SUPPL. 1
- Alter, M.J.¹

3
- 0034981872
- Management of recurrent hepatitis C after liver transplantation
- (2001) J Viral Hepatitis , vol.8 , pp. 159-168
- Teixeira, R.¹ Papatheodoridis, G.V.² Burroughs, A.K.³

4
- 0032850293
- Developments in hepatitis C during 1997-1999
- (1999) Exp Opin Ther Pat , vol.9 , pp. 1249-1262
- Poordad, F.F.¹ Gish, R.G.²

5
- 0033965268
- Current therapy for chronic hepatitis C
- note
- (2000) Gastroenterology , vol.118
- Davis, G.L.¹

6
- 0032585237
- Randomized trial of interferon α-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α-2b plus placebo for 48 weeks for treatment of chronic hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷ Heathcote, J.⁸ Zuezem, S.⁹ Trepo, C.¹⁰ Albrecht, J.¹¹

7
- 0032547938
- Interferon α2-b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) New Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.D.⁷ Ling, M.H.⁸ Cort, S.⁹ Albrecht, J.K.¹⁰

8
- 0034619946
- Peginterferon α-2a in patients with chronic hepatitis C
- note
- (2000) New Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³ Heathcote, E.J.⁴ Lai, M.-Y.⁵ Gane, E.⁶ O'Grady, J.⁷ Reichen, J.⁸ Diago, M.⁹ Lin, A.¹⁰ Hoffman, J.¹¹ Brunda, M.J.¹²

9
- 0034619980
- Peginterferon α-2a in patients with chronic hepatitis C and cirrhosis
- note
- (2000) New Engl J Med , vol.343 , pp. 1673-1680
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, W.G.E.³ Dusheiko, G.M.⁴ Lee, S.S.⁵ Balart, L.⁶ Reindollar, R.⁷ Reddy, R.K.⁸ Wright, T.L.⁹ Lin, A.¹⁰ Hoffman, J.¹¹ Pamphilis, J.¹²

10
- 0000947620
- Pegylated interferon α-2b (Peg-Intron) monotherapy is superior to interferon α-2b (Intron A) for the treatment of chronic hepatitis C
- (2000) J Hepatol , vol.32 , Issue.SUPPL. 2 , pp. 29
- Trepo, C.¹ Lindsay, K.² Niederau, C.³

11
- 4243774750
- Pegylated (40kDa) interferon α-2a (Pegasys) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
- Abs 289
- (2001) Digestive Disease Week AASLD Presidential Plenary I
- Fried, M.W.¹

12
- 0006634013
- Data on file, Schering-Plough Corp, Kenilworth, NJ, USA
- (2001) Comparison of Peg-Interferon α-2b (Intron A, SCH 30500) Plus Rebetol for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects

13
- 0033429914
- Molecular virology of the hepatitis C virus
- (1999) J Hepatol , vol.31 , pp. 47-53
- De Francesco, R.¹

14
- 0027436831
- A second hepatitis C viruss encoded proteinase
- (1993) Proc Natl Acad Sci USA , vol.90 , pp. 10583-10587
- Grakoui, A.¹ McCourt, D.W.² Wychowski, C.³ Feinstone, S.M.⁴ Rice, C.M.⁵

15
- 0031766374
- The hepatitis C virus NS3 proteinase: Structure and function of a zinc-containing serine proteinase
- (1998) Antiviral Therapy , vol.3 , Issue.SUPPL. 3 , pp. 99-109
- De Francesco, R.¹ Pessi, A.² Steinkuhler, C.³

16
- 0029970903
- The helicase activity associated with hepatitis C virus non-structural protein 3 (NS3)
- (1996) J Virol , vol.70 , pp. 8477-8484
- Tai, C.-L.¹ Chi, W.-K.² Chen, D.-S.³ Hwang, L.-H.⁴

17
- 0033692476
- Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase
- note
- (2000) Curr Opin Invest Drugs , vol.1 , pp. 289-296
- Lesburg, C.A.¹ Radfar, R.² Weber, P.C.³

18
- 0035947270
- How hepatitis C virus counteracts the interferon response: The jury is still out on NS5A
- (2001) Virology , vol.284 , pp. 1-12
- Tan, S.-L.¹ Katze, M.G.²

19
- 0033920304
- Hepatitis C virus encoded enzymatic activities and conserved RNA elements in the 3′ non-translated region are essential for virus replication in vivo
- (2000) J Virol , vol.74 , pp. 2046-2051
- Kolykhalov, A.A.¹ Mihalik, K.² Feinstone, S.M.³ Rice, C.M.⁴

20
- 0034940307
- Hepatitis C virus serine protease inhibitors: Current progress and future challenges
- note
- (2001) Curr Med Chem , vol.8 , pp. 919-932
- Steinkuhler, C.¹ Koch, U.² Narjes, F.³ Matassa, V.G.⁴

21
- 16044364658
- Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
- (1996) Cell , vol.87 , pp. 343-355
- Kim, J.L.¹ Morgenstern, K.A.² Lin, C.³ Fox, T.⁴ Dwyer, M.D.⁵ Landro, J.A.⁶ Chambers, S.P.⁷ Markland, W.⁸ Lepre, C.A.⁹ O'Malley, E.T.¹⁰ Harbeson, S.L.¹¹ Rice, C.M.¹² Murcko, M.A.¹³ Caron, P.R.¹⁴ Thomson, J.A.¹⁵

22
- 2642590958
- Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form
- (1998) Protein Sci , vol.7 , pp. 837-847
- Yan, Y.¹ Li, Y.² Munshi, S.³ Sardana, V.⁴ Cole, J.L.⁵ Sardana, M.⁶ Steinkuhler, C.⁷ Tomei, L.⁸ DeFrancesco, R.⁹ Kuo, L.C.¹⁰ Chen, Z.¹¹

23
- 0033571623
- Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase
- (1999) Structure Fold Des , vol.7 , pp. 1353-1363
- Yao, N.¹ Reichart, P.² Taremi, S.S.³ Prosise, W.W.⁴ Weber, P.C.⁵

24
- 0033603427
- Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain
- (1999) J Biol Chem , vol.274 , pp. 18618-18624
- La Plante, S.R.¹ Cameron, D.R.² Aubry, N.³ Lefebvre, S.⁴ Kukolj, G.⁵ Maurice, R.⁶ Thibeault, D.⁷ Lamarre, D.⁸ Llinas-Brunet, M.⁹

25
- 0034629363
- Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes
- (2000) J Biol Chem , vol.275 , pp. 7152-7157
- Di Marco, S.¹ Rizzi, M.² Volpari, C.³ Walsh, M.A.⁴ Narjes, F.⁵ Colarusso, S.⁶ De Francesco, R.⁷ Matassa, V.G.⁸ Sollazzo, M.⁹

26
- 0032821515
- The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase
- (1999) Antiviral Chem Chemother , vol.10 , pp. 259-273
- Attwood, M.R.¹ Bennett, J.M.² Campbell, A.D.³ Canning, G.G.M.⁴ Carr, M.G.⁵ Conway, E.⁶ Dundson, R.M.⁷ Greening, J.R.⁸ Jones, P.S.⁹ Kay, P.B.¹⁰ Handa, B.K.¹¹ Hurst, D.N.¹² Jennings, N.S.¹³ Jordan, S.¹⁴ Keech, E.¹⁵ O'Brien, M.A.¹⁶ Overton, H.A.¹⁷ King-Underwood, J.¹⁸ Raynham, T.M.¹⁹ Stenson, K.P.²⁰ more..

27
- 0035847669
- The identification of α-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinase
- (2001) Bioorg Med Chem Lett , vol.11 , pp. 355-357
- Bennett, J.M.¹ Campbell, A.D.² Campbell, A.J.³ Carr, M.G.⁴ Dunsdon, R.M.⁵ Greening, J.R.⁶ Hurst, D.N.⁷ Jennings, N.S.⁸ Jones, P.S.⁹ Jordan, S.¹⁰ Kay, P.B.¹¹ O'Brien, M.A.¹² King-Underwood, J.¹³ Raynham, T.M.¹⁴ Wilkinson, C.S.¹⁵ Wilkinson, T.C.I.¹⁶ Wilson, F.X.¹⁷

28
- 0034700964
- α-Ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease
- (2000) Biochemistry , vol.39 , pp. 1849-1861
- Narjes, F.¹ Brunetti, M.² Colarusso, S.³ Gerlach, B.⁴ Koch, U.⁵ Biasiol, G.⁶ Fattori, D.⁷ DeFrancesco, R.⁸ Matassa, V.G.⁹ Steinkuhler, C.¹⁰

29
- 0038343796
- Product inhibition of the hepatitis C virus NS3 protease
- (1998) Biochemistry , vol.37 , pp. 8899-8905
- Steinkuhler, C.¹ Biasiol, G.² Brunetti, M.³ Urbani, A.⁴ Koch, U.⁵ Cortesse, R.⁶ Pessi, A.⁷ DeFrancesco, R.⁸

30
- 0032493405
- Peptide based inhibitors of the hepatitis C virus serine protease
- (1998) Bioorg Med Chem Lett , vol.8 , pp. 1713-1718
- Llinas-Brunet, M.¹ Bailey, M.² Fazal, G.³ Goulet, S.⁴ Halmos, T.⁵ LaPlante, S.⁶ Maurice, R.⁷ Poirier, M.⁸ Poupart, M.-A.⁹ Thibeault, D.¹⁰ Wernic, D.¹¹ Lamarre, D.¹²

31
- 0032560602
- Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimising the cleavage products
- (1998) Biochemistry , vol.37 , pp. 8906-8914
- Ingallinella, P.¹ Altamura, S.² Bianchi, E.³ Taliani, M.⁴ Ingenito, R.⁵ Cortese, R.⁶ DeFrancesco, R.⁷ Steinkuhler, C.⁸ Pessi, A.⁹

32
- 0034675706
- Highly potent and selective peptide based inhibitors of the hepatitis C virus serine protease: Towards smaller inhibitors
- note
- (2000) Bioorg Med Chem Lett , vol.10 , pp. 2267-2270
- Llinas-Brunet, M.¹ Bailey, M.² Fazal, G.³ Ghiro, E.⁴ Gorys, V.⁵ Goulet, S.⁶ Halmos, T.⁷ Maurice, R.⁸ Poirier, M.⁹ Poupart, M.-A.¹⁰ Rancourt, J.¹¹ Thibeault, D.¹² Wernic, D.¹³ Lamarre, D.¹⁴

33
- 0035931471
- Arylalkylidene rhodanine with bulky and hydrophobic functional groups as selective HCV NS3 protease inhibitor
- (2001) Bioorg Med Chem Lett , vol.11 , pp. 91-94
- Wan, T.S.¹ Cheng, L.L.² Su, L.Y.³ Siew, P.L.⁴ Mui, M.S.⁵

34
- 0033571463
- Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
- (1999) Structure Fold Des , vol.7 , pp. 1417-1426
- Ago, H.¹ Adachi, T.² Yoshida, A.³ Yamamoto, M.⁴ Habuka, N.⁵ Yatsunami, K.⁶ Miyano, M.⁷

35
- 0033539482
- Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
- (1999) Proc Natl Acad Sci USA , vol.96 , pp. 13034-13039
- Bressanelli, S.¹ Tomei, L.² Roussel, A.³ Incitti, I.⁴ Vitale, R.L.⁵ Mathieu, M.⁶ DeFrancesco, R.⁷ Rey, F.A.⁸

36
- 0032876683
- Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
- (1999) Nature Struct Biol , vol.6 , pp. 937-943
- Lesburg, C.A.¹ Cable, M.B.² Ferrari, E.³ Hong, Z.⁴ Mannarino, A.F.⁵ Weber, P.C.⁶

37
- 0003325020
- Diketobutanoic acids as HCV Pol inhibitors
- Gold Coast, Queensland, Australia
- (2000) 7th International Meeting on Hepatitis and Related Viruses (Molecular Virology and Pathogenesis)
- DeFrancesco, R.¹

38
- 0033992576
- Structure and function of hepatitis C virus NS3 helicase
- (2000) Curr Top Microbiol Immunol , vol.242 , pp. 171-196
- Kwong, A.D.¹ Kim, J.L.² Lin, C.³

39
- 0032518490
- Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding
- (1998) Structure , vol.6 , pp. 89-100
- Kim, J.L.¹ Morgenstern, K.A.² Griffith, J.P.³ Dwyer, M.D.⁴ Thomson, J.A.⁵ Murcko, M.A.⁶ Lin, C.⁷ Caron, P.R.⁸

40
- 0033816721
- Combination treatment for chronic hepatitis C: What is the role of ribavirin
- note
- (2000) Fundam Clin Pharmacol , vol.14 , pp. 321-325
- Souvignet, C.¹ Zarski, J.-P.²

41
- 0032775451
- Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents
- (1999) Curr Med Chem , vol.6 , pp. 599-614
- Franchetti, P.¹ Grifantini, M.²

42
- 0006675152
- Direct antiviral activity of ribavirin: Hepatitis C virus NS5B polymerase incorporates ribavirin triphosphate into nascent RNA products
- Dallas, TX, USA; Abs 773
- (1999) 50th Annual Meeting of AASLD
- Hong, Z.¹ Ferrari, E.² Wright-Minogue, J.³ Skelton, A.⁴ Glu, P.⁵ Zhong, W.⁶ Lau, J.Y.N.⁷

43
- 0034532953
- The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
- (2000) Nature Med , vol.6 , pp. 1375-1379
- Crotty, S.¹ Maag, D.² Arnold, J.J.³ Zhong, W.⁴ Lau, J.Y.N.⁵ Hong, Z.⁶ Andino, R.⁷ Cameron, C.E.⁸

44
- 0033024781
- Ribavirin polarises human T-cell responses towards a type 1 cytokine profile
- (1999) J Hepatol , vol.30 , pp. 376-382
- Tam, R.C.¹ Pai, B.² Bard, J.³ Lim, C.⁴ Averett, D.R.⁵ Phan, U.T.⁶ Milovanovic, T.⁷

45
- 0033960092
- Hepatitis C virus specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
- (2000) Gastroenterology , vol.118 , pp. 346-355
- Cramp, M.E.¹ Rossol, S.² Chokshi, S.³ Carucci, P.⁴ Williams, R.⁵ Naoumov, N.V.⁶

46
- 0034090556
- The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels
- (2000) Antimicrob Agents Chemother , vol.44 , pp. 1276-1283
- Tam, R.C.¹ Ramasamy, K.² Bard, J.³ Pai, B.⁴ Lim, C.⁵ Averett, D.R.⁶

47
- 0006634014
- Roche acquires Hepatitis C drug rights from ICN
- July 2
- (2001) Financial Times Report
- Firn, D.¹

48
- 0034102651
- Broad-spectrum antiviral activity of the IMP dehydrogenease inhibitor VX-497: A comparison with ribavirin and demonstration of antiviral additivity with α-interferon
- (2000) Antimicrob Agents Chemother , vol.44 , pp. 859-866
- Markland, W.¹ McQuaid, T.J.² Jain, J.³ Kwong, A.D.⁴

49
- 0345188811
- Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
- note
- (1999) Science , vol.285 , pp. 110-113
- Lohmann, V.¹ Korner, F.² Koch, J.³ Herian, U.⁴ Theilmann, L.⁵ Bartenschlager, R.⁶

50
- 0342633156
- WO-09901582
- (1999) Screening Methods Using an ATPase Protein from a Virus of the Flaviviridae Family
- Delvecchio, A.¹ Zhong, W.²

51
- 0141790302
- WO-00009543
- (2000) Heatitis C Inhibitor Tripeptides
- Llinas-Brunet, M.¹ Bailey, M.D.² Cameron, D.³ Faucher, A.-M.⁴ Ghiro, E.⁵ Goudreau, N.⁶ Halmos, T.⁷ Poupart, M.-A.⁸ Rancourt, J.⁹ Tsantrizos, Y.S.¹⁰ Wemic, D.M.¹¹ Simoneau, B.¹²

52
- 0006638320
- WO-00020400
- (2000) Novel Compounds and Compositions for Treating Hepatitis C Infections
- Hataye, J.M.¹ Rice, K.² Shelton, E.J.³ Spencer, J.R.⁴ Wang, V.R.⁵

53
- 33645204275
- WO-00006529
- (2000) Diketoacid-derivatives as Inhibitors of Polymerases
- Altamura, S.¹ Tomei, L.² Koch, U.³ Neuner, P.J.S.⁴ Summa, V.⁵

54
- 0006719387
- WO-00013708
- (2000) Methods for Treating or Preventing Viral Infections and Associated Diseases
- Bailey, T.R.¹ Young, D.C.²

55
- 0006716009
- WO-00010573
- (2000) Compounds, Compositions and Methods for Treating or Preventing Viral Infections and Associated Diseases
- Bailey, T.R.¹ Young, D.C.²

56
- 0006719388
- WO-00024725
- (2000) Pentacyclic Compounds Useful as Inhibitors of Hepatitis C Virus NS3 Helicase
- Janetka, J.W.¹ Ledford, B.E.² Mullican, M.D.³

57
- 0006634336
- WO-00107027
- (2001) Inhibitors of Viral Helicase
- Hale, M.¹ Maltais, F.² Baker, C.³ Janetka, J.⁴ Moon, Y.C.⁵ Saunders, J.⁶

58
- 0006705027
- WO-09736554
- (1997) Piperidine Derivatives, Pharmaceutical Compositions Thereof and Their Use in the Treatment of Hepatitis C
- Diana, G.D.¹ Bailey, T.R.² Nitz, T.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.